Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Trials that have examined efficacy of GLP-1RA therapies include Evaluation of Lixisenatide in Acute Coronary Syndrome [ELIXA] trial, 47 Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results [LEADER] trial, 6 Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes [SUSTAIN-6], 49 oral administration of semaglutide in the Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes [PIONEER-6], 50 once-weekly exenatide in the Exenatide Study of Cardiovascular Event Lowering [EXSCEL] trial, 51 albiglutide in the Harmony Outcomes trial, 52 and dulaglutide in the Researching Cardiovascular Events With a Weekly Incretin in Diabetes [REWIND] trial, 53 among others
Kono T, Nozaki M, Kikuchi Y, et al
What works for you may not work for your sister or best friend
Women requiring reliable contraception while on tirzepatide therapy should discuss contraceptive options with their prescribing provider
FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S
Thyroid (MTC/MEN-2): Boxed warning remains
